Search results
Find out the latest news and updates from Novartis, a global leader in medicine and healthcare. Browse media releases, stories, statements, reports and more from the frontiers of medicine.
- Novartis Resumes Business in Ukraine
News; Novartis Resumes Business In Ukraine; Novartis resumes...
- News Archive
Novartis a poursuivi au T2 la forte croissance de son...
- Media Library
The Novartis in Society Integrated Report covers our...
- Stay Up-to-Date
Novartis is an innovative medicines company. Every day, we...
- Sandoz Spin-Off
Oct 4, 2023. Novartis executes Sandoz Spin-off, completing...
- Novartis Live. Magazine
Novartis Live. Magazine - News | Novartis
- Media Contacts
Find contacts at Novartis for media and journalist inquiries...
- Novartis Resumes Business in Ukraine
Sep 22, 2022 · Novartis executives share insights into the updated company strategy, focusing on five core therapeutic areas, key technology platforms, and the US market. The strategy is underpinned by eight potential multi-billion dollar brands and a deep pipeline of high-value NMEs.
Apr 4, 2022 · Novartis unveils a simplified structure and operating model to support its innovation, growth and productivity ambitions as a focused medicines company. The changes include integrating Pharmaceuticals and Oncology business units, creating a new Strategy & Growth function, and combining Technical Operations and Customer & Technology Solutions units.
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be...
Jul 18, 2024 · Swiss pharma giant Novartis AG (NYSE:NVS) reported a second-quarter adjusted EPS of $1.97, up 21% year over year (+17% on constant currency), beating the consensus of $1.89. The company’s sales ...
Jul 18, 2024 · Sales of the drug rose by 45 per cent in the six months to the end of June to $655mn, Novartis reported on Thursday, with $522mn in the US. However, sales in the second quarter — up 44 per cent ...
Mar 15, 2024 · Novartis today announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying digital...